A multivariate analysis of acute severe cholangitis and the establishment and evaluation of a risk prediction scoring model

Hongyu XIANG; Zheng DANG; Shulin XU; Gang NIU; Yuesheng LI; Baiwen MIAO; Yaoping PANG; Ruifang FAN; Jianwei QIN

doi:10.3969/j.issn.1001-5256.2022.08.024

Volume 38 Issue 8

Aug. 2022

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2022 > 38(8): 1847-1853

PDF( 2651 KB)

A multivariate analysis of acute severe cholangitis and the establishment and evaluation of a risk prediction scoring model

DOI: 10.3969/j.issn.1001-5256.2022.08.024

1.
Department of Hepatobiliary Surgery, The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou 730000, China
2.
Medical College of Northwest Minzu University, Lanzhou 730000, China

Research funding:

Applied Basic Research Prcject of Logistics Support Department of the Military Commission (20BJZ23)

More Information

Corresponding author: QIN Jianwei, qinjianwei@163.com(ORCID: 0000-0001-7663-1894)
Received Date: 2021-12-05
Accepted Date: 2022-01-06
Published Date: 2022-08-20

Abstract

Abstract

Objective To investigate the independent risk factors for acute severe cholangitis and related protective factors, and to construct a risk prediction scoring model for acute severe cholangitis. Methods A retrospective analysis was performed for the clinical data of 381 patients with acute cholangitis who were admitted to Department of Hepatobiliary Surgery, The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, from January 2016 to July 2021, among whom there were 273 patients with non-severe cholangitis and 108 patients with severe cholangitis. Univariate and multivariate logistic regression analyses were used to screen out the independent risk factors for acute severe cholangitis and related protective factors, and then a logistic regression model was established. The receiver operating characteristic (ROC) curve was used to evaluate the discriminatory ability of the model, the calibration curve was used to evaluate the prediction accuracy of the model, and decision curve analysis (DCA) was used to evaluate the clinical value of the model. Moreover, the enhanced Bootstrap method was used to perform internal validation of the model and evaluate the performance of the model in internal validation. The model was visualized by the construction of Web calculator, nomogram, and scoring system. The two-independent-samples t test was used for comparison of normally distributed continuous data between groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between groups; the chi-square test was used for comparison of categorical data between groups. Results The univariate and multivariate logistic regression analyses showed that total bilirubin (TBil) (odds ratio [OR]=1.014, 95% confidence interval [CI]: 1.009-1.020, P < 0.001), percentage of neutrophils (OR=1.128, 95%CI: 1.088-1.175, P < 0.001), and age (OR=1.053, 95%CI: 1.027-1.082, P < 0.001) were independent risk factors, and albumin (Alb) (OR=0.871, 95%CI: 0.817-0.924, P < 0.001) was a protective factor. The above independent risk factors and protective factor were included in the logistic regression analysis for model fitting, and the predictive model obtained had an area under the ROC curve (AUC) of 0.925 (95%CI: 0.897-0.952), with a specificity of 0.817 and a sensitivity of 0.935 at the optimal cut-off value of 0.245. The calibration curve showed that the predicted probability of the model was approximately equal to the actual probability, with a Brier value of 0.098, and the decision curve analysis showed that the model had a higher net income within the threshold probability interval of 0.1-0.9. Internal validation showed an AUC_{internal validation} of 0.915 and a Brier value_{internal verification} of 0.106. Conclusion TBil, percentage of neutrophils, and age are independent risk factors for acute severe cholangitis, while Alb is a protective factor. The established risk prediction scoring model has good discriminatory ability, calibration, and clinical value and can identify patients with acute severe cholangitis at an early stage, which provides a reference for subsequent diagnosis and treatment.
- Cholangitis,
- Logistic Models,
- Risk Factors

FullText(HTML)

References(23)

References

[1]	Biliary Surgery Group, Surgery Branch of Chinese Medical Association. Guidelines for diagnosis and treatment of acute biliary tract infections(2021)[J]. Chin J Surg, 2021, 59(6): 422-429. DOI: 10.3760/cma.j.cn112139-20210421-00180. 中华医学会外科学分会胆道外科学组. 急性胆道系统感染的诊断和治疗指南(2021版)[J]. 中华外科杂志, 2021, 59(6): 422-429. DOI: 10.3760/cma.j.cn112139-20210421-00180.
[2]	KIRIYAMA S, KOZAKA K, TAKADA T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos)[J]. J Hepatobiliary Pancreat Sci, 2018, 25(1): 17-30. DOI: 10.1002/jhbp.512.
[3]	YANG DX, ZHANG Y, WANG XF, et al. Application of ultrasound-guided real - time percutaneous transhepatic-cholangial or transhepatic-cholecyst drainage in treatment of acute obstructive cholangitis in primary hospitals[J]. J Clin Hepatol, 2020, 36(4): 847-849. DOI: 10.3969/j.issn.1001-5256.2020.04.027. 杨东晓, 张勇, 王雪峰, 等. 超声实时引导下经皮经肝胆管或胆囊穿刺置管引流术治疗急性梗阻性胆管炎在基层医院的应用[J]. 临床肝胆病杂志, 2020, 36(4): 847-849. DOI: 10.3969/j.issn.1001-5256.2020.04.027.
[4]	ZHANG Z, ZHAO BM. Successful emergency treatment of esophageal and gastric varices bleeding complicated with acute obstructive suppurative cholangitis: A case report[J/CD]. Chin J Gastrointestinal Endosc (Electronic Edition), 2020, 7(4): 211-212. DOI: 10.3877/cma.j.issn.2095-7157.2020.04.009. 张哲, 赵保民. 食管胃静脉曲张破裂出血合并急性梗阻性化脓性胆管炎急诊救治成功1例[J/CD]. 中华胃肠内镜电子杂志, 2020, 7(4): 211-212. DOI: 10.3877/cma.j.issn.2095-7157.2020.04.009.
[5]	LU W, SUN DX, GAO JH, et al. Overview of big data analysis of precision medicine and modeling key technologies[J]. Chin Hosp Manage, 2021, 41(5): 19-25. https://www.cnki.com.cn/Article/CJFDTOTAL-YYGL202105009.htm 路薇, 孙东旭, 高景宏, 等. 面向精准医疗的大数据分析与建模关键技术综述[J]. 中国医院管理, 2021, 41(5): 19-25. https://www.cnki.com.cn/Article/CJFDTOTAL-YYGL202105009.htm
[6]	KÖNIG IR, FUCHS O, HANSEN G, et al. What is precision medicine?[J]. Eur Respir J, 2017, 50(4): 1700391. DOI: 10.1183/13993003.00391-2017.
[7]	KIRIYAMA S, TAKADA T, HWANG TL, et al. Clinical application and verification of the TG13 diagnostic and severity grading criteria for acute cholangitis: an international multicenter observational study[J]. J Hepatobiliary Pancreat Sci, 2017, 24(6): 329-337. DOI: 10.1002/jhbp.458.
[8]	TRAUNER M, FICKERT P, STAUBER RE. Inflammation-induced cholestasis[J]. J Gastroenterol Hepatol, 1999, 14(10): 946-959. DOI: 10.1046/j.1440-1746.1999.01982.x.
[9]	STRNAD P, TACKE F, KOCH A, et al. Liver - guardian, modifier and target of sepsis[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(1): 55-66. DOI: 10.1038/nrgastro.2016.168.
[10]	Y₁LD₁Z BD, ÖZDEN S, SAYLAM B, et al. Simplified scoring system for prediction of mortality in acute suppurative cholangitis[J]. Kaohsiung J Med Sci, 2018, 34(7): 415-419. DOI: 10.1016/j.kjms.2017.12.016.
[11]	SCHWED AC, BOGGS MM, PHAM XD, et al. Association of admission laboratory values and the timing of endoscopic retrograde cholangiopancreatography with clinical outcomes in acute cholangitis[J]. JAMA Surg, 2016, 151(11): 1039-1045. DOI: 10.1001/jamasurg.2016.2329.
[12]	ZHANG F, LIU AL, GAO S, et al. Neutrophil dysfunction in sepsis[J]. Chin Med J (Engl), 2016, 129(22): 2741-2744. DOI: 10.4103/0366-6999.193447.
[13]	DU HW, QIN MF, WANG Q, et al. Analysis of mortality risk factors for acute cholangitis of severse type[J]. Shandong Med J, 2013, 53(7): 29-31. DOI: 10.3969/j.issn.1002-266X.2013.07.010. 杜海伟, 秦鸣放, 王庆, 等. 重症急性胆管炎患者的死亡风险因素分析[J]. 山东医药, 2013, 53(7): 29-31. DOI: 10.3969/j.issn.1002-266X.2013.07.010.
[14]	GONG JP, WU CX, LIU CA, et al. Liver sinusoidal endothelial cell injury by neutrophils in rats with acute obstructive cholangitis[J]. World J Gastroenterol, 2002, 8(2): 342-345. DOI: 10.3748/wjg.v8.i2.342.
[15]	WANG RF, LYU Y, ZHANG XG. Advances in the diagnosis and treatment of severe acute cholangitis[J]. J Clin Hepatol, 2019, 35(12): 2622-2626. DOI: 10.3969/j.issn.1001-5256.2019.12.002. 王荣峰, 吕毅, 张晓刚. 重症胆管炎的诊断与治疗[J]. 临床肝胆病杂志, 2019, 35(12): 2622-2626. DOI: 10.3969/j.issn.1001-5256.2019.12.002.
[16]	CHENG XY, NIU Q, WANG J, et al. Clinical value of emergency endoscopic retrograde cholangiopancreatography in the treatment of acute severe cholangitis secondary to common bile duct stones in the elderly[J]. Chin J Gerontol, 2022, 42(6): 1381-1384. DOI: 10.3969/j.issn.1005-9202.2022.06.031. 程宪永, 牛琼, 王健, 等. 急诊ERCP治疗老年人胆总管结石继发急性重症胆管炎的临床价值[J]. 中国老年学杂志, 2022, 42(6): 1381-1384. DOI: 10.3969/j.issn.1005-9202.2022.06.031.
[17]	QIN YS, LI QY, YANG FC, et al. Risk factors and incidence of acute pyogenic cholangitis[J]. Hepatobiliary Pancreat Dis Int, 2012, 11(6): 650-654. DOI: 10.1016/s1499-3872(12)60240-9.
[18]	LIU Q, ZHOU Q, SONG M, et al. A nomogram for predicting the risk of sepsis in patients with acute cholangitis[J]. J Int Med Res, 2020, 48(1): 300060519866100. DOI: 10.1177/0300060519866100.
[19]	YIN M, SI L, QIN W, et al. Predictive value of serum albumin level for the prognosis of severe sepsis without exogenous human albumin administration: a prospective cohort study[J]. J Intensive Care Med, 2018, 33(12): 687-694. DOI: 10.1177/0885066616685300.
[20]	KENDALL H, ABREU E, CHENG AL. Serum albumin trend is a predictor of mortality in ICU patients with sepsis[J]. Biol Res Nurs, 2019, 21(3): 237-244. DOI: 10.1177/1099800419827600.
[21]	ARNAU-BARRÉS I, GVERRI-FERNÁNDEZ R, LUQUE S, et al. Serum albumin is a strong predictor of sepsis outcome in elderly patients[J]. Eur J Clin Microbiol Infect Dis, 2019, 38(4): 743-746. DOI: 10.1007/s10096-019-03478-2.
[22]	SCHNEIDER J, HAPFELMEIER A, THÖRES S, et al. Mortality risk for acute cholangitis (MAC): a risk prediction model for in-hospital mortality in patients with acute cholangitis[J]. BMC Gastroenterol, 2016, 16: 15. DOI: 10.1186/s12876-016-0428-1.
[23]	GRAVITO-SOARES E, GRAVITO-SOARES M, GOMES D, et al. Clinical applicability of Tokyo guidelines 2018/2013 in diagnosis and severity evaluation of acute cholangitis and determination of a new severity model[J]. Scand J Gastroenterol, 2018, 53(3): 329-334. DOI: 10.1080/00365521.2018.1430255.

Relative Articles

[1]	Jing KUANG, Shuangqin TENG, Tongtong SHEN, Yiran YAN, Wei WANG, Chuan SHEN, Caiyan ZHAO. Risk factors for portopulmonary hypertension in liver cirrhosis and construction of a predictive model[J]. Journal of Clinical Hepatology, 2024, 40(9): 1802-1806. doi: 10.12449/JCH240914
[2]	Linna YUAN, Yihui CHEN, Hengbin NA, Jie LU, Ye LIU, Wu LI. Primary biliary cholangitis with metabolic associated fatty liver disease： Clinical features and risk factors[J]. Journal of Clinical Hepatology, 2024, 40(8): 1598-1604. doi: 10.12449/JCH240815
[3]	Di WU, Dahua DAI, Wenmei LIANG, Bao FU, Xiaoyun FU. Clinical features of acute pancreatitis in pregnancy and related risk factors[J]. Journal of Clinical Hepatology, 2024, 40(5): 1009-1015. doi: 10.12449/JCH240522
[4]	Chengsi ZHAO, Weijie YAO, Peng YUAN, Zuozheng WANG. Time distribution of risk factors for secondary pancreatic infection in acute pancreatitis[J]. Journal of Clinical Hepatology, 2022, 38(7): 1686-1690. doi: 10.3969/j.issn.1001-5256.2022.07.044
[5]	Yu LIANG, Yuanhong ZHAO, Zheng LI. Recent advancement in research on intrahepatic cholangiocarcinoma: Risk factors and pathogenesis[J]. Journal of Clinical Hepatology, 2022, 38(10): 2391-2395. doi: 10.3969/j.issn.1001-5256.2022.10.037
[6]	Yu LIU, Xue MEI, Yuyi ZHANG, Ying ZOU, Zhengguo ZHANG, Hongying GUO, Wei YUAN, Jiefei WANG, Zhiping QIAN. Clinical features and risk factors of acute hepatitis E with severe jaundice[J]. Journal of Clinical Hepatology, 2021, 37(3): 565-569. doi: 10.3969/j.issn.1001-5256.2021.03.013
[7]	Cao Yuan, Yao GuoXiang, Shi YiHai. An excerpt of international consensus guidelines for risk factors in chronic pancreatitis (2020)[J]. Journal of Clinical Hepatology, 2020, 36(8): 1720-1722. doi: 10.3969/j.issn.1001-5256.2020.08.008
[8]	Lin DongYi, Peng Bo, Zheng JingHui, Wang ZongYu, Li HanZhong, He JianBo, Li KeZhi, Wu GuoBin, Chen Chuang. Value of a logistic regression model based on the clinical features of liver cancer in judging the traditional Chinese medicine syndrome types of primary liver cancer[J]. Journal of Clinical Hepatology, 2020, 36(6): 1293-1298. doi: 10.3969/j.issn.1001-5256.2020.06.021
[9]	Liu HongJin, Bao ChunMei, Bai WenLin, Li YinYin, Rong GuangHua, Lu YinYing, Chen Yan, Liu Ze, Cheng JiaMin, Ceng Zhen. Risk factors for infectious complications in primary liver cancer[J]. Journal of Clinical Hepatology, 2018, 34(5): 1033-1037. doi: 10.3969/j.issn.1001-5256.2018.05.021
[10]	Chang XiuJuan, Lu YinYing, Rong GuangHua, Liu Ze, Chen Yan, Xu GuiLin, Gao XuDong, Lou Min, Wang ChunPing, Yang YongPing, Ceng Zhen. Risk factors for vascular invasion of primary liver cancer[J]. Journal of Clinical Hepatology, 2018, 34(5): 1038-1041. doi: 10.3969/j.issn.1001-5256.2018.05.022
[11]	Wang FengJiao, Liu MingJiang, Wu RuiHong, Niu JunQi. A multivariate logistic regression analysis of short-term prognosis of patients with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2017, 33(4): 711-714. doi: 10.3969/j.issn.1001-5256.2017.04.022
[12]	Wang ChunQiu, Ma YingCai, Zhu ZhiYong, Yuan Ling. Risk factors for pyogenic cholangitis in patients with common bile duct stones[J]. Journal of Clinical Hepatology, 2017, 33(1): 95-97. doi: 10.3969/j.issn.1001-5256.2017.01.020
[13]	Zhang Yu. High-risk factors for cholangitis after endoscopic sphincterotomy[J]. Journal of Clinical Hepatology, 2017, 33(7): 1316-1319. doi: 10.3969/j.issn.1001-5256.2017.07.022
[14]	YIERPAN Aishan, Gao Feng. Risk factors for hyperamylasemia after endoscopic retrograde cholangiopancreatography[J]. Journal of Clinical Hepatology, 2016, 32(1): 119-122. doi: 10.3969/j.issn.1001-5256.2016.01.022
[15]	Cui YanPing, Liu FengHua, Shi QingFeng, Zhao HongKui, Wang SiKui. Logistic regression analysis of prognostic factors in 106 acute-on-chronic liver failure patients with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2014, 30(10): 992-995. doi: 10.3969/j.issn.1001-5256.2014.10.005
[16]	Gao Rui, Liu ZhongJing, Chen Fei, Gao Lei, Jiang ChuanWu. Multivariate regression analysis of risk factors for HBV-related primary liver cancer[J]. Journal of Clinical Hepatology, 2014, 30(4): 370-372. doi: 10.3969/j.issn.1001-5256.2014.04.021
[17]	Zhang ZhanQing, Lu Wei, Wang YanBing, Jia XiaoFang, Zhang LiJun, Ding RongRong, Zhou XinLan, Feng YanLing. Diagnosis of hepatic fibrosis in hepatitis B patients by logistic regression modeling based on plasma amino acid ratio and age[J]. Journal of Clinical Hepatology, 2013, 29(5): 330-335.
[18]	Lu: RiYing, Li ShiXiong, Wu JiZhou, Zhu YuJia, Fu ShaoPing. Development of a prognostic factors model for severe hepatitis[J]. Journal of Clinical Hepatology, 2012, 28(10): 789-792.
[19]	Dou WeiJia, Zhou Lin, Wu KaiChun. Risk factors of chronic pancreatitis[J]. Journal of Clinical Hepatology, 2011, 27(11): 1180-1183.

Supplements(0)

Cited By

Cited by

Periodical cited type(4)

1.	毕玉珍，周利民. 胆管末端良性病变并胆管炎经内镜下逆行胆胰管造影术后胆管炎复发的危险因素分析. 大医生. 2024(05): 90-92 .
2.	张靖宇，马路平，尹世航，刘星. 老年胆总管结石继发急性重症胆管炎的病原菌构成、耐药性及驱动因素. 川北医学院学报. 2024(10): 1415-1419 .
3.	严朝成，古雅，白韬，李云峰. 三镜联合鼻胆管引流术与两镜T管引流在急性重症胆管炎中的疗效比较. 重庆医学. 2024(21): 3279-3283 .
4.	王鸿飞，何志强，俞松松，尹京兆，吴天俣. 胆总管结石并发急性胆管炎危险因素分析及预测模型构建. 山东医药. 2024(32): 88-91 .

Other cited types(3)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(6) / Tables(4)

Get Citation

PDF

XML

Article Metrics

Article views (577) PDF downloads(61)

A multivariate analysis of acute severe cholangitis and the establishment and evaluation of a risk prediction scoring model

DOI: 10.3969/j.issn.1001-5256.2022.08.024